Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance Glox Therapeutics, a company pioneering the development of precision antib ...

Glox Therapeutics’ proprietary protein bacteriocin engineering platform allows for the development of potent therapeutics that selectively eradicate drug-resistant pathogenic bacteria.

Here, we review the different expression systems for bacteriocin production using this host and identify the most important features to guarantee successful production of a range of bacteriocins. In ...

2006; Settanni and Corsetti, 2008). This review focuses on the classification of bacteriocins from Gram-negative and Gram-positive bacteria. The application of bacteriocin-producing bacteria and ...